GLYCOTOPE is a global leader in optimizing the glycosylation of biopharmaceuticals
GlycoExpress is one of the broadest platform technologies for the development and production of glycosylated proteins.
A clinical pipeline of 4 glycooptimized BioBetters and NBEs underlines GLYCOTOPE´s and its manufacturing arm GLYCOTOPE BIOTECHNOLOGY´s competence to contribute significant improvements to healthcare.